How Novavax plans to advance after failed drug trial, delisting threat

Washington Business Journal

May 9, 2019

Novavax Inc.'s CEO continues to maintain a sunny outlook despite the storm clouds hovering over the company. After kicking off 2019 with positive phase 2 results for flu vaccine ca…